Literature DB >> 24294411

Small-Molecule Allosteric Activation of Human Glucokinase in the Absence of Glucose.

Joseph M Bowler1, Katherine L Hervert, Mark L Kearley, Brian G Miller.   

Abstract

Synthetic allosteric activators of human glucokinase are receiving considerable attention as potential diabetes therapeutic agents. Although their mechanism of action is not fully understood, structural studies suggest that activator association requires prior formation of a binary enzyme-glucose complex. Here, we demonstrate that three previously described activators associate with glucokinase in a glucose-independent fashion. Transient-state kinetic assays reveal a lag in enzyme progress curves that is systematically reduced when the enzyme is preincubated with activators. Isothermal titration calorimetry demonstrates that activator binding is enthalpically driven for all three compounds, whereas the entropic changes accompanying activator binding can be favorable or unfavorable. Viscosity variation experiments indicate that the kcat value of glucokinase is almost fully limited by product release, both in the presence and absence of activators, suggesting that activators impact a step preceding product release. The observation of glucose-independent allosteric activation of glucokinase has important implications for the refinement of future diabetes therapeutics and for the mechanism of kinetic cooperativity of mammalian glucokinase.

Entities:  

Keywords:  Maturity onset diabetes of the young type II; glucokinase activators; hysteretic enzyme; kinetic cooperativity

Year:  2013        PMID: 24294411      PMCID: PMC3840467          DOI: 10.1021/ml400061x

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  36 in total

1.  Discovery, synthesis and biological evaluation of novel glucokinase activators.

Authors:  Darren McKerrecher; Joanne V Allen; Suzanne S Bowker; Scott Boyd; Peter W R Caulkett; Gordon S Currie; Christopher D Davies; Mark L Fenwick; Harold Gaskin; Emma Grange; Rod B Hargreaves; Barry R Hayter; Roger James; Keith M Johnson; Craig Johnstone; Clifford D Jones; Sarah Lackie; John W Rayner; Rolf P Walker
Journal:  Bioorg Med Chem Lett       Date:  2005-04-15       Impact factor: 2.823

2.  Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors.

Authors:  Oliver Anderka; Janina Boyken; Ursula Aschenbach; Andreas Batzer; Oliver Boscheinen; Dieter Schmoll
Journal:  J Biol Chem       Date:  2008-09-22       Impact factor: 5.157

3.  Design, synthesis and SAR of novel glucokinase activators.

Authors:  Zacharia S Cheruvallath; Stephen L Gwaltney; Mark Sabat; Mingnam Tang; Jun Feng; Haixia Wang; Joanne Miura; Prasuna Guntupalli; Andy Jennings; David Hosfield; Bumsup Lee; Yiqin Wu
Journal:  Bioorg Med Chem Lett       Date:  2013-02-04       Impact factor: 2.823

4.  Transients and cooperativity. A slow transition model for relating transients and cooperative kinetics of enzymes.

Authors:  G R Ainslie; J P Shill; K E Neet
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

5.  Kinetic aspects of regulation of metabolic processes. The hysteretic enzyme concept.

Authors:  C Frieden
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

6.  Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study.

Authors:  Riccardo C Bonadonna; Tim Heise; Christophe Arbet-Engels; Christoph Kapitza; Angelo Avogaro; Joe Grimsby; Jay Zhi; Joseph F Grippo; Raffaella Balena
Journal:  J Clin Endocrinol Metab       Date:  2010-08-25       Impact factor: 5.958

Review 7.  Glucokinase activators for the potential treatment of type 2 diabetes.

Authors:  J Grimsby; S J Berthel; R Sarabu
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

Review 8.  Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.

Authors:  Anna L Gloyn
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

Review 9.  Glucokinase activators: molecular tools for studying the physiology of insulin-secreting cells.

Authors:  D Johnson; R M Shepherd; D Gill; T Gorman; D M Smith; M J Dunne
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

10.  Investigation of diffusion-limited rates of chymotrypsin reactions by viscosity variation.

Authors:  A C Brouwer; J F Kirsch
Journal:  Biochemistry       Date:  1982-03-16       Impact factor: 3.162

View more
  6 in total

1.  Mechanistic Origins of Enzyme Activation in Human Glucokinase Variants Associated with Congenital Hyperinsulinism.

Authors:  Shawn M Sternisha; Peilu Liu; Alan G Marshall; Brian G Miller
Journal:  Biochemistry       Date:  2018-02-20       Impact factor: 3.162

Review 2.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

3.  Dual allosteric activation mechanisms in monomeric human glucokinase.

Authors:  A Carl Whittington; Mioara Larion; Joseph M Bowler; Kristen M Ramsey; Rafael Brüschweiler; Brian G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

4.  Role of connecting loop I in catalysis and allosteric regulation of human glucokinase.

Authors:  Juliana A Martinez; Mioara Larion; Maria S Conejo; Carol M Porter; Brian G Miller
Journal:  Protein Sci       Date:  2014-04-30       Impact factor: 6.725

5.  A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.

Authors:  Matthew G Rees; Mindy I Davis; Min Shen; Steve Titus; Anne Raimondo; Amy Barrett; Anna L Gloyn; Francis S Collins; Anton Simeonov
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

6.  Biochemical and biophysical investigations of the interaction between human glucokinase and pro-apoptotic BAD.

Authors:  Alix Rexford; Diego A R Zorio; Brian G Miller
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.